Jonsson Comprehensive Cancer Center: Neoplasms trials

The registry lists 13 Neoplasms studies with Jonsson Comprehensive Cancer Center as lead sponsor. 2 are open to participants now and 0 have results posted.

Early Phase 1 2Phase 1 3Phase 2 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell TransplantRecruitingNCT04453072Not applicable
• Germ-Line Mutations in Blood and Saliva Samples From Patients With CancerRecruitingNCT02280161
• Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine NeoplasmsActive, not recruitingNCT06788938Phase 2
• MR Correlated Spectroscopic Imaging for Diagnosing Breast CancerCompletedNCT06090630Early Phase 1
• 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyTerminatedNCT04928820Phase 2
• Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain MetastasesWithdrawnNCT04069910Not applicable
• Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced CancerTerminatedNCT03240861Phase 1
• 18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After InterventionsTerminatedNCT02888301
• MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver CancerCompletedNCT02683200Early Phase 1
• Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation TherapyTerminatedNCT02310594
• Gene and Vaccine Therapy in Treating Patients With Advanced MalignanciesActive, not recruitingNCT01697527Phase 2
• SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid TumorsStatus unknownNCT00005996Phase 1
• Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid TumorsCompletedNCT00004979Phase 1/2